Matinas BioPharma Holdings, Inc. (MTNB) Stock Price, News, Quote & History - Yahoo Finance

By Yahoo! Finance | Sep 2, 2024 at 09:43 AM EST

Matinas BioPharma Holdings is a biopharmaceutical company using lipid nanocrystal technology to develop various pharmaceutical products. Its lead product, MAT2203, is in Phase 3 trials for fungal infections. They collaborate with various organizations for drug development.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.